Page last updated: 2024-08-25

frovatriptan and Recrudescence

frovatriptan has been researched along with Recrudescence in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egan, CG; Mogavero, S; Savi, L	1
Guidotti, M; Ravasio, R	1
Wallasch, TM	1
Campbell, JC; Harper, SQ; Hu, X; Kelman, L	1
Göbel, H; Heinze, A	1
Balbisi, EA	1
Cady, R; Elkind, A; Goldstein, J; Keywood, C	1
Silberstein, SD	1
Goldstein, J; Keywood, C; Rapoport, A; Ryan, R	1

Reviews

2 review(s) available for frovatriptan and Recrudescence

Article	Year
Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting. Clinical drug investigation, 2009, Volume: 29, Issue:11 Topics: Acute Disease; Administration, Oral; Carbazoles; Drug Costs; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Tryptamines	2009
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. International journal of clinical practice, 2004, Volume: 58, Issue:7 Topics: Carbazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2004

Article

Year

Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.

Clinical drug investigation, 2009, Volume: 29, Issue:11

Topics: Acute Disease; Administration, Oral; Carbazoles; Drug Costs; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Tryptamines

2009

Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.

International journal of clinical practice, 2004, Volume: 58, Issue:7

Topics: Carbazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines

2004

Trials

4 trial(s) available for frovatriptan and Recrudescence

Article	Year
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine. Drug design, development and therapy, 2014, Volume: 8 Topics: Adult; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Tryptamines	2014
Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN. Advances in therapy, 2010, Volume: 27, Issue:1 Topics: Acute Disease; Adult; Carbazoles; Female; Humans; Male; Middle Aged; Migraine Disorders; Office Visits; Physicians, Family; Product Surveillance, Postmarketing; Recurrence; Serotonin Receptor Agonists; Time Factors; Tryptamines	2010
Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Current medical research and opinion, 2004, Volume: 20, Issue:9 Topics: Adult; Carbazoles; Cross-Over Studies; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Migraine Disorders; Pain Measurement; Recurrence; Tryptamines	2004
Dose range-finding studies with frovatriptan in the acute treatment of migraine. Headache, 2002, Volume: 42 Suppl 2 Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; United States	2002

Other Studies

4 other study(ies) available for frovatriptan and Recrudescence

Article	Year
Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Current medical research and opinion, 2010, Volume: 26, Issue:9 Topics: Adult; Analgesics; Carbazoles; Female; Germany; Humans; Male; Middle Aged; Migraine Disorders; Product Surveillance, Postmarketing; Recurrence; Self Report; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Tryptamines	2010
The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study. International journal of clinical practice, 2011, Volume: 65, Issue:8 Topics: Acute Disease; Adult; Aged; Carbazoles; Female; Humans; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Self Medication; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Tryptamines; Young Adult	2011
[After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans]. MMW Fortschritte der Medizin, 2003, Oct-16, Volume: 145, Issue:42 Topics: Analgesics, Non-Narcotic; Carbazoles; Ergotamine; Humans; Migraine Disorders; Recurrence; Time Factors; Tryptamines; Vasoconstrictor Agents	2003
Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction. Headache, 2002, Volume: 42 Suppl 2 Topics: Acute Disease; Carbazoles; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Tryptamines	2002